Advertisement

Tumor Biology

, Volume 36, Issue 7, pp 5249–5254 | Cite as

REG Iα activates c-Jun through MAPK pathways to enhance the radiosensitivity of squamous esophageal cancer cells

  • Akiyuki Wakita
  • Satoru Motoyama
  • Yusuke Sato
  • Souichi Koyota
  • Shuetsu Usami
  • Kei Yoshino
  • Tomohiko Sasaki
  • Kazuhiro Imai
  • Hajime Saito
  • Yoshihiro Minamiya
Research Article

Abstract

Identification of the key molecules that mediate susceptibility to anticancer treatments would be highly desirable. Based on clinical and cell biological studies, we recently proposed that regenerating gene (REG) Iα may be such a molecule. In the present study, we hypothesized that REG Iα increases radiosensitivity through activation of mitogen-activated protein kinase (MAPK) pathways. To test that idea, we transfected TE-5 and TE-9 squamous esophageal cancer cells with REG Iα and examined its involvement in MAPK signaling and its effect on susceptibility to radiotherapy. We found that REG Iα-expressing cells showed increased expression of c-Jun messenger RNA (mRNA) and phospho-c-Jun protein mediated via the c-Jun N-terminal kinase (JNK) pathway and extracellular signal-regulated kinase (ERK) pathway, as well as increased radiosensitivity. Immunohistochemical analysis confirmed the activation of c-Jun in tumors expressing REG Iα. Collectively, these findings suggest that REG Iα activates c-Jun via the JNK and ERK pathway, thereby enhancing radiosensitivity.

Keywords

REG I MAPK Radiosensitivity c-Jun JNK ERK 

Notes

Acknowledgments

This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture.

References

  1. 1.
    Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3) N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425–33.CrossRefPubMedGoogle Scholar
  2. 2.
    Ishikura S, Nihei K, Outhu A, Boku N, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21:2697–702.CrossRefPubMedGoogle Scholar
  3. 3.
    Yoshino K, Motoyama S, Koyota S, Shibuya K, Usami S, Maruyama K, et al. IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells. J Biochem Biophys Res Commun. 2011;404:1070–5.CrossRefGoogle Scholar
  4. 4.
    Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, et al. A novel gene activated in regenerating islets. J Biol Chem. 1988;263:2111–4.PubMedGoogle Scholar
  5. 5.
    Moriizumi S, Watanabe T, Unno M, Nakagawara K, Suzuki Y, Miyashita H, et al. Isolation, structural determination and expression of a novel reg gene, human regI beta. Biochim Biophys Acta. 1994;1217:199–202.CrossRefPubMedGoogle Scholar
  6. 6.
    Unno M, Itoh T, Watanabe T, Miyashita H, Moriizumi S, Teraoka H, et al. Islet beta-cell regeneration and reg genes. Adv Exp Med Biol. 1992;321:61–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Miyaoka Y, Kadowaki Y, Ishihara S, Ose T, Fukuhara H, Kazumori H, et al. Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene. 2004;23:3572–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Yonemura Y, Sakurai S, Yamamoto H, Endou Y, Kawamura T, Bandou E, et al. REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer. 2003;98:1394–400.CrossRefPubMedGoogle Scholar
  9. 9.
    Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, et al. Expression of reg I alpha protein in human gastric cancers. Digestion. 2004;69:177–84.CrossRefPubMedGoogle Scholar
  10. 10.
    Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, et al. Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer. 2004;100:1130–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Usami S, Motoyama S, Koyota S, Wang J, Hayashi-Shibuya K, Maruyama K, et al. Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells. Biochem Biophys Res Commun. 2010;392:4–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, et al. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann Surg Oncol. 2006;13:1724–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, et al. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann Surg Oncol. 2008;15:1224–31.CrossRefPubMedGoogle Scholar
  14. 14.
    Hayashi K, Motoyama S, Koyota S, Koizumi Y, Wang J, Takasawa S, et al. REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci. 2008;99:2491–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911–2.CrossRefPubMedGoogle Scholar
  16. 16.
    Plotnikov A, Zehorai E, Procaccia S, Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta. 1813;2011:1619–33.Google Scholar
  17. 17.
    Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279–90.CrossRefPubMedGoogle Scholar
  18. 18.
    Leppä S, Saffrich R, Ansorge W, Bohmann D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 1998;17:4404–13.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003;22:3876–86.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Takasawa S, Ikeda T, Akiyama T, Nata K, Nakagawa K, Shervani NJ, et al. Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration. FEBS Lett. 2006;580:585–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, et al. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis. 2008;29:76–83.CrossRefPubMedGoogle Scholar
  22. 22.
    Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene. 2003;22:5885–96.CrossRefPubMedGoogle Scholar
  23. 23.
    Bossy-Wetzel E, Bakiri L, Yaniv M. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 1997;16:1695–709.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 2013;4:401–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991;353:670–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Kovary K, Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol. 1991;11:4466–72.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Coco Martin JM, Balkenende A, Verschoor T, Lallemand F, Michalides R. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res. 1999;59:1134–40.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Akiyuki Wakita
    • 1
  • Satoru Motoyama
    • 1
    • 3
  • Yusuke Sato
    • 1
  • Souichi Koyota
    • 2
  • Shuetsu Usami
    • 1
  • Kei Yoshino
    • 1
  • Tomohiko Sasaki
    • 1
  • Kazuhiro Imai
    • 1
  • Hajime Saito
    • 1
  • Yoshihiro Minamiya
    • 1
  1. 1.Department of Surgery, Graduate School of MedicineAkita UniversityAkitaJapan
  2. 2.Department of Biochemistry, Graduate School of MedicineAkita UniversityAkitaJapan
  3. 3.Department of Comprehensive Cancer Control, Graduate School of MedicineAkita UniversityAkitaJapan

Personalised recommendations